Abstract: Background: Eclampsia affects 1 in 2000 to 1 in 3448 individuals in developed countries. Eclampsia affects 0.9 to 1.8% of Indians. In India, the maternal mortality rate is 212 per 1 lakh, with hypertensive disorders accounting for 5% of maternal mortality.
Objectives: To study the Maternal outcomes analysis in women with low dose of magnesium sulphate (Dhaka regime)
Methods: A total of 100 cases were selected and divided into 2 groups of 50 patients each. Dhaka regime was used in 1 group and Pritchard regime was used in another. Complete history was obtained from close relatives as well as the patient if she is conscious, including age, parity, gestational age, number of convulsions, persistence of symptoms of pregnancy-induced hypertension, and H/o impending signs. Any previous history of hypertension (or) renal illness (or) eclampsia (or) eclampsia in a previous pregnancy was elicited.
Results: In the Dhaka regime group, Overall maternal complications was reported in 26% of the cases. In 8% of the cases each, HELLP syndrome and abruption was reported, DIC in 6% of the cases, PPH and CVA in 2% of the cases each. Eclampsia accounted for 6% of maternal mortality.
Conclusion: This study concludes that low-dose magnesium sulphate was equally effective and safer than the Pritchard regime.
Indexed in Index Copernicus
